Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-041565

Chief Medical Officer gave up 1,360 shares (to pay taxes)

  • Chief Medical Officer acquired 6,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gordon David N. Chief Medical Officer 2020-07-02 Option exercise +6,000 88,895 D
Gordon David N. Chief Medical Officer 2020-07-02 Shares withheld for taxes −1,360 $1.50 $2,040 87,535 D
Derivatives
Gordon David N. Chief Medical Officer 2020-07-02 Option exercise · Restricted stock units −6,000 12,000 D
Loading xslF345X03/doc4.xml…